The following article was recently published in the news.

An experimental pill that allows people to float could soon be rolled out worldwide. Air Ltd the company that makes the drug says it will soon submit an application to regulators seeking provisional approval for the tablet. The drug is currently moving to a phase $3$ trial involving more than $100,000$ people around the world.

Air Ltd has just completed a phase $2$ trial which is about efficacy. At the highest dose tolerable without side effects, the study found that people could remain floating for up to one hour. The noted Nobel prize winning scientist Dr Bunsen Honeydew from Fluffy Duck University indicated that $$this tablet will be the largest ever breakthrough in pharmaceuticals.$$ It is reported that $100$ million courses of the drug may be ordered by global retailers pending the medical watchdog authorising the tablets use.

Required

Assuming Air Ltd applies Australian accounting standards, provide a discussion on how the costs associated with the tablet should be accounted for $($no journal entries needed$).$